In vitro and in vivo activity of 3-alkoxy-1,2-dioxolanes against Schistosoma mansoni

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 8, 2012, Pages 1979-1986

  Ingram, Katrin ^a,b   Schiaffo, Charles E ^c   Sittiwong, Wantanee ^c   Benner, Evan ^c   Dussault, Patrick H ^c   Keiser, Jennifer ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Chemotherapy; Non peroxidic analogues; Peroxides; Schistosomiasis

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; 3 ALKOXY 1,2 DIOXOLANE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; ECHINOSTOMA; ECHINOSTOMA CAPRONI; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ANIMALS; ANTHELMINTICS; DIOXOLANES; DISEASE MODELS, ANIMAL; ECHINOSTOMA; ECHINOSTOMIASIS; FEMALE; INHIBITORY CONCENTRATION 50; MICE; SCHISTOSOMA MANSONI; STRUCTURE-ACTIVITY RELATIONSHIP; TREATMENT OUTCOME;

EID: 84864522601     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks141     Document Type: Article

References (26)

1. Gryseels B, Polman K, Clerinx J et al. Human schistosomiasis. Lancet 2006; 368: 1106-18.
2. Steinmann P, Keiser J, Bos R et al. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006; 6: 411-25.
3. Li HJ, Wang W, Li YZ et al. Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum. Parasitol Res 2011; 109: 515-9.
4. Keiser J, Utzinger J. Artemisinins and synthetic trioxolanes in the treatment of helminth infections. Curr Opin Infect Dis 2007; 20: 605-12.
5. Keiser J, N'Guessan NA, Adoubryn KD et al. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clin Infect Dis 2011; 50: 1205-13.
6. Xiao SH, Keiser J, Chollet J et al. In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. Antimicrob Agents Chemother 2007; 51: 1440-5.
7. Boissier J, Cosledan F, Robert A et al. In vitro activities of trioxaquines against Schistosoma mansoni. Antimicrob Agents Chemother 2009; 53: 4903-6.
8. Keiser J, Ingram K, Vargas M et al. In vivo activity of next generation synthetic ozonides against Schistosoma species. Antimicrob Agents Chemother 2012; 56: 1090-2.
9. Wang X, Dong Y, Wittlin S et al. Spiro- and dispiro-1,2-dioxolanes: contribution of iron(II)-mediated one-electron vs two-electron reduction to the activity of antimalarial peroxides. J Med Chem 2007; 50: 5840-7.
10. Schiaffo CE, Rottman M, Wittlin S et al. 3-Alkoxy-1,2-dioxolanes: synthesis and evaluation as potential antimalarial agents. ACS Med Chem Lett 2011; 2: 316-9.
11. O'Neill PM, Barton VE, Ward SA. The molecular mechanism of action of artemisinin-the debate continues. Molecules 2010; 15: 1705-21.
12. Keiser J. In vitro and in vivo trematode models for chemotherapeutic studies. Parasitology 2009; 137: 589-603.
13. Manneck T, Haggenmuller Y, Keiser J. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni. Parasitology 2009; 137: 85-98.
14. Cousin CE, Stirewalt MA, Dorsey CH et al. Schistosoma mansoni: comparative development of schistosomules produced by artificial techniques. J Parasitol 1986; 72: 606-9.
15. Ramirez B, Bickle Q, Yousif F et al. Schistosomes: challenges in compound screening. Exp Opin Drug Discov 2007; 2 Suppl 1: S53-61.
16. Manneck T, Braissant O, Haggenmuller Y et al. Isothermal microcalorimetry to study drugs against Schistosoma mansoni. J Clin Microbiol 2011; 49: 1217-25.
17. Manneck T, Braissant O, Ellis W et al. Schistosoma mansoni: antischistosomal activity of the four optical isomers and the two racemates of mefloquine on schistosomula and adult worms in vitro and in vivo. Exp Parasitol 2011; 127: 260-9.
18. Utzinger J, Chollet J, Tu Z et al. Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice. Trans R Soc Trop Med Hyg 2002; 96: 318-23.
19. Martyn DC, Beletsky G, Cortese JF et al. Synthesis and in vitro DMPK profiling of a 1,2-dioxolane-based library with activity against Plasmodium falciparum. Bioorg Med Chem Lett 2009; 19: 5657-60.
20. de Villiers KA, Egan TJ. Recent advances in the discovery of haem-targeting drugs for malaria and schistosomiasis. Molecules 2009; 14: 2868-87.
21. Wang X, Creek DJ, Schiaffo CE et al. Spiroadamantyl 1,2,4-trioxolane, 1,2,4-trioxane, and 1,2,4-trioxepane pairs: relationship between peroxide bond iron(II) reactivity, heme alkylation efficiency, and antimalarial activity. Bioorg Med Chem Lett 2009; 19: 4542-5.
22. Xiao SH, Xue J, Mei JY et al. Effectiveness of synthetic trioxolane OZ78 against Schistosoma japonicum in mice and rabbits. Parasitol Res 2011; doi:10.1007/s00436-011-2765-x.
23. Ingram K, Ellis W, Keiser J. Antischistosomal activities of melfoquine related arylmethanols. Antimicrob Agents Chemother 2012; doi:10.1128/AAC.06177-11.
24. Zhao Q, Vargas M, Dong Y et al. Structure-activity relationship of an ozonide carboxylic acid (OZ78) against Fasciola hepatica. J Med Chem 2010; 53: 4223-33.
25. Haynes RK, Pai HH-O, Voerste A. Ring opening of artemisinin (qinghaosu) and dihydroartemisinin and interception of the open hydroperoxides with formation of N-oxides: a chemical model for antimalarial mode of action. Tetrahedron Lett 1999; 40: 4715-8.
26. Keiser J, Manneck T, Vargas M. Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro. J Antimicrob Chemother 2011; 66: 1791-7.